Bioline RX Ltd (NASDAQ:BLRX)
| 1.63 Data as of 11:50am ET |  -0.01 / -0.61%Today’s Change | 1.55 Today|||52-Week Range 5.10 | -35.57% Year-to-Date |
Latest BLRX News | Press Releases
| BioLineRx Enrolls First Patient in Study - Analyst Blog Jun 07 / Zacks.com |
Today’s Trading
| Previous close | 1.64 |
| Today’s open | 1.63 |
| Day’s range | 1.60 - 1.64 |
| Volume | 29,500 |
| Average volume (3 months) | 152,135 |
| Market cap | $36.5M |
| Dividend yield | -- |
Data as of 11:50am ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IPCIIntellipharmaceutics... | -0.05 | -2.50% |
| --BioZone Pharmaceutic... | 0.00 | 0.00% |
| IDRAIdera Pharmaceutical... | -0.01 | -1.35% |
| BGMDBG Medicine Inc | -0.01 | -0.69% |
Data as of 11:50am ET, 06/19/2013
Financials
| Next reporting date | August 14, 2013 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters --, -- |
Forecasts
